Prior case reports have described CLL1 CAR-T bridging to transplantation in R/R AML (10) and CLL1 CAR-T treatment for post-transplant AML relapse (8), both utilizing donor-derived CLL1 CAR-T cells. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.